Taking a Patient-Centric Approach to Mobile and Patient-Facing Technologies in Clinical Trials

Patrick is Executive Director, Head of Global Clinical Trial Services at Regeneron where he oversees global site management, central monitoring, study feasibility and site selection, as well as study/site start up, eCOA and patient technology initiatives. He joined Regeneron a little over 5 years ago. Patrick worked at Pfizer for 25 years before joining Regeneron, mostly in clinical program operations. He also held roles in GCP Quality (level 1) and Analytics. Patrick has extensive international drug development experience, as he helped establish the Pfizer country office development teams in Latin America, India and other parts of Asia. He later served as the Head of Japan Development Operations and Development Japan Portfolio &Project Management Groups for 10 years in Pfizer’s Development Japan organization.